Bionano Genomics, Inc.
BNGO
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $13.4M
$1.17
▼ -3.31%
P/E
—
Mkt Cap
$13.4M
52-Wk Range
$1.00–$5.50
52-Week Range
$1.00 - $5.50
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 69.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary Optical Genome Mapping Technology - Superior to traditional sequencing for structural variation detection
- Comprehensive Clinical Testing Portfolio - Integrated diagnostics covering developmental, neurological, and psychiatric conditions
- Established Laboratory Infrastructure - CLIA-certified testing services with growing patient base
- Differentiated Market Position - Less competitive landscape compared to traditional NGS providers
Bear Case
1 risk
- Above-average volatility (beta 1.6).
Growth
Strong growth ahead
Increasing adoption of structural variant analysis in clinical diagnostics and research
Value
Valuation data unavailable
Momentum
Weak
-5.7% over 3m
Quality
Strong
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying BNGO right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
AUG 10, 2026
Reported EPS of -$0.64 vs -$0.67 consensus (+4.5% surprise). Revenue of $8.2M vs $7.6M expected (+8.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+4.5%
Revenue trend · last 8Q
—
—
-26%
-13%
+21%
-3%
-100%
+21%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$6.1M
$8.2M
$6.5M
$6.7M
$7.4M
$8.0M
$6.7K
$8.2M
Margins · last 8Q
Gross
54.4%
Operating
-88.3%
Profit
-90.8%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: HC Wainwright · Apr 13, 2026
vs Industry
How BNGO stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related